|
|
|
| |
|
|
<![CDATA[<code id='7F28542384'></code><style id='7F28542384'></style>]]> | <![CDATA[<acronym id='7F28542384'></acronym>]]><![CDATA[<center id='7F28542384'><center id='7F28542384'><tfoot id='7F28542384'></tfoot></center><abbr id='7F28542384'><dir id='7F28542384'><tfoot id='7F28542384'></tfoot><noframes id='7F28542384'>]]>
| <![CDATA[<optgroup id='7F28542384'><strike id='7F28542384'><sup id='7F28542384'></sup></strike><code id='7F28542384'></code></optgroup>]]>
| |
|
|
| <![CDATA[<b id='7F28542384'><label id='7F28542384'><select id='7F28542384'><dt id='7F28542384'><span id='7F28542384'></span></dt></select></label></b><u id='7F28542384'></u>]]> | |
<![CDATA[<i id='7F28542384'><strike id='7F28542384'><tt id='7F28542384'><pre id='7F28542384'></pre></tt></strike></i>]]>|
Activists slam private health insurers over coverage restrictions 
Novo Nordisk testing Wegovy against alcohol 
Dobbs anniversary: the lost opportunity of abortion as health care 
The United States must get value 
Novavax promises a turnaround & Lilly roils the obesity market 
Lilly’s weekly insulin works as well as daily products, new studies show 
Ohio still needs to do more to protect the right to abortion 
Duchenne breakthrough therapy leaves behind pioneering families 
ALS treatment from Biogen, Ionis fails in study 
Drug repurposing or repositioning? The language matters 
Apple is now the first public company to be valued at $3 trillion 
Readout Newsletter: Zepbound, Valneva's vaccine, and more 
Jerome Adams on the need for new antivirals for Covid 
